Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q1

6523.TEDINET S100OZNU
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥81.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥340.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥80.9bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥2.0bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥5.6bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax−¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥3.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥14.1bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥7.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥8.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥10.4bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥7.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥10.4bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥595.7bnat 2022-06-30Cons.Assets IFRS
Total assets¥591.3bnat 2022-03-31Cons.Assets IFRS
Total assets¥571.4bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥458.0bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥455.3bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥137.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥119.6bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥107.6bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥136.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥135.4bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥119.0bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥82.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥57.5bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.8bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥51.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥13.8bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥5.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥12.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥4.7bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥11.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥7.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥13.0bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-57.262022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-70.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥89.392021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-57.262022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-70.782021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥86.312021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio23.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio22.9%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio20.8%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥6.7bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥80.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥80.9bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.8bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30¥940m
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-06-30¥940m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥3.1bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2021-04-01 → 2021-06-30¥26.3bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2021-04-01 → 2021-06-30¥26.3bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2021-04-01 → 2021-06-30¥21.9bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2021-04-01 → 2021-06-30¥21.9bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.7bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2021-04-01 → 2021-06-30¥31.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2021-04-01 → 2021-06-30¥31.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.6bn
—segment totalrevenue2021-04-01 → 2021-06-30¥80.0bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥80.0bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥8.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 810
ItemContextValueUnit
Borrowings cl IFRSCurrentQuarterInstant28259000000JPY
Income taxes payable cl IFRSPrior1YearInstant3219000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant4078000000JPY
Provisions cl IFRSPrior1YearInstant5019000000JPY
Provisions cl IFRSCurrentQuarterInstant6641000000JPY
Other financial liabilities cl IFRSPrior1YearInstant5707000000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant6213000000JPY
Other current liabilities cl IFRSPrior1YearInstant27745000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant28721000000JPY
Total current liabilities IFRSPrior1YearInstant137745000000JPY
Total current liabilities IFRSCurrentQuarterInstant139564000000JPY
Trade and other payables ncl IFRSPrior1YearInstant1942000000JPY
Trade and other payables ncl IFRSCurrentQuarterInstant1864000000JPY
Borrowings ncl IFRSPrior1YearInstant280685000000JPY
Borrowings ncl IFRSCurrentQuarterInstant283538000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant8214000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant7110000000JPY
Provisions ncl IFRSPrior1YearInstant3277000000JPY
Provisions ncl IFRSCurrentQuarterInstant3373000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant10076000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant10096000000JPY
Deferred tax liabilities IFRSPrior1YearInstant11789000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant10790000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant1524000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant1661000000JPY
Non current labilities IFRSPrior1YearInstant317509000000JPY
Non current labilities IFRSCurrentQuarterInstant318435000000JPY
Liabilities IFRSPrior1YearInstant455255000000JPY
Liabilities IFRSCurrentQuarterInstant457999000000JPY
Share capital IFRSPrior1YearInstant47065000000JPY
Share capital IFRSCurrentQuarterInstant47431000000JPY
Capital surplus IFRSPrior1YearInstant44118000000JPY
Capital surplus IFRSCurrentQuarterInstant43509000000JPY
Retained earnings IFRSPrior1YearInstant28353000000JPY
Retained earnings IFRSCurrentQuarterInstant18211000000JPY
Treasury shares IFRSPrior1YearInstant-568000000JPY
Treasury shares IFRSCurrentQuarterInstant-568000000JPY
Other components of equity IFRSPrior1YearInstant16406000000JPY
Other components of equity IFRSCurrentQuarterInstant28278000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant135374000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant136863000000JPY
Non controlling interests IFRSPrior1YearInstant690000000JPY
Non controlling interests IFRSCurrentQuarterInstant818000000JPY
Equity IFRSPrior1YearInstant136065000000JPY
Equity IFRSCurrentQuarterInstant137681000000JPY
Liabilities and equity IFRSPrior1YearInstant591320000000JPY
Liabilities and equity IFRSCurrentQuarterInstant595681000000JPY
Revenue IFRSPrior1YTDDuration80909000000JPY
Revenue IFRSCurrentYTDDuration81502000000JPY
Cost of sales IFRSPrior1YTDDuration41117000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass